Ablacon Inc Funding & Investors

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system. We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE). If you are looking for the next big challenge, a wonderful team and a purpose that literally saves lives, you might want to consider joining us.